RS20050384A - Estri karbaminske kiseline sa antiholinergičkim dejstvom - Google Patents

Estri karbaminske kiseline sa antiholinergičkim dejstvom

Info

Publication number
RS20050384A
RS20050384A YUP-2005/0384A YUP20050384A RS20050384A RS 20050384 A RS20050384 A RS 20050384A YU P20050384 A YUP20050384 A YU P20050384A RS 20050384 A RS20050384 A RS 20050384A
Authority
RS
Serbia
Prior art keywords
acid esters
carbamic acid
anticholinergic action
pharmaceutical compositions
anticholinergic
Prior art date
Application number
YUP-2005/0384A
Other languages
English (en)
Inventor
Matthias Grauert
Matthias Hoffmann
Michael Pieper
Georg Speck
Steffen Breitfelder
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg., filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.,
Publication of RS20050384A publication Critical patent/RS20050384A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Predmetni pronalazak se odnosi na nove estre karbaminske kiseline opšte formule 1 u kojoj X- i grupe A, R1, R2, R3 i R4 mogu imati značenja koja su navedena u patentnim zahtevima i opisu pronalaska, na postupke za njihovo dobijanje, kao i na njihovu primenu u farmaceutskim kompozicijama, a naročito farmaceutskim kompozicijama sa antiholinergičkim dejstvom.
YUP-2005/0384A 2002-11-26 2003-11-19 Estri karbaminske kiseline sa antiholinergičkim dejstvom RS20050384A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (de) 2002-11-26 2002-11-26 Neue Carbaminsäureester mit anticholinerger Wirksamkeit
PCT/EP2003/012912 WO2004048373A1 (de) 2002-11-26 2003-11-19 Carbaminsäureester mit anticholinerger wirksamkeit

Publications (1)

Publication Number Publication Date
RS20050384A true RS20050384A (sr) 2007-12-31

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0384A RS20050384A (sr) 2002-11-26 2003-11-19 Estri karbaminske kiseline sa antiholinergičkim dejstvom

Country Status (20)

Country Link
EP (1) EP1567526B1 (sr)
JP (1) JP4754829B2 (sr)
KR (1) KR20050086821A (sr)
CN (1) CN1717408A (sr)
AT (1) ATE392424T1 (sr)
AU (1) AU2003289880A1 (sr)
BR (1) BR0316549A (sr)
CA (1) CA2507110C (sr)
DE (2) DE10255040A1 (sr)
EA (1) EA200500775A1 (sr)
EC (1) ECSP055803A (sr)
ES (1) ES2304538T3 (sr)
HR (1) HRP20050465A2 (sr)
MX (1) MXPA05005443A (sr)
NO (1) NO20053089L (sr)
PL (1) PL376638A1 (sr)
RS (1) RS20050384A (sr)
UA (1) UA81649C2 (sr)
WO (1) WO2004048373A1 (sr)
ZA (1) ZA200502946B (sr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004021921D1 (de) 2003-05-28 2009-08-20 Theravance Inc Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
EP1765339A4 (en) * 2004-06-30 2009-09-02 Glaxo Group Ltd ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
US20090142279A1 (en) * 2004-11-15 2009-06-04 Budzik Brian W Novel m3 muscarinic acetylcholine receptor antagonists
WO2007007282A2 (en) * 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
US20090182033A1 (en) * 2005-12-16 2009-07-16 Argenta Discovery Ltd. Cyclic Amine Derivatives and Their Uses
KR20090107567A (ko) 2007-02-09 2009-10-13 아스텔라스세이야쿠 가부시키가이샤 아자 가교환 화합물
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
EP3710483A4 (en) 2017-11-16 2021-10-20 XL-protein GmbH PASYLATED VEGFR / PDGFR FUSION PROTEINS AND THEIR USE IN THERAPY
JP2021505569A (ja) * 2017-12-04 2021-02-18 フリードリヒ−アレクサンダー−ウニヴェルシテート エアランゲン−ニュルンベルク Ｍ２よりもｍ３に対して選択性を有するフルオロフェニル置換ムスカリン受容体リガンド
KR20220001259A (ko) 2020-06-29 2022-01-05 (주)아모레퍼시픽 표면처리된 무기입자, 이의 제조방법, 이의 분산액 및 이를 포함하는 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (fr) * 1969-11-26 1971-05-26 Knoll Ag Nouveaux carbamates et leur procede de preparation
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
WO1995006635A1 (fr) * 1993-09-02 1995-03-09 Yamanouchi Pharmaceutical Co., Ltd. Derive de carbamate et medicament le contenant
KR970701174A (ko) * 1994-02-10 1997-03-17 오노다 마사요시 신규한 카바메이트 유도체 및 이의 의약 조성물(Novel carbamate derivative and medicinal composition containing the same)
ES2342990T3 (es) * 1996-03-20 2010-07-20 Wake Forest University Health Sciences Receptores sigma-2 como biomarcadores de proliferacion de celulas tumorales.

Also Published As

Publication number Publication date
MXPA05005443A (es) 2005-08-03
CA2507110A1 (en) 2004-06-10
JP2006514010A (ja) 2006-04-27
ATE392424T1 (de) 2008-05-15
JP4754829B2 (ja) 2011-08-24
HRP20050465A2 (en) 2006-10-31
DE50309655D1 (de) 2008-05-29
AU2003289880A1 (en) 2004-06-18
CN1717408A (zh) 2006-01-04
EP1567526A1 (de) 2005-08-31
ES2304538T3 (es) 2008-10-16
PL376638A1 (pl) 2006-01-09
EP1567526B1 (de) 2008-04-16
NO20053089D0 (no) 2005-06-23
KR20050086821A (ko) 2005-08-30
CA2507110C (en) 2012-07-10
UA81649C2 (ru) 2008-01-25
BR0316549A (pt) 2005-10-04
ECSP055803A (es) 2005-08-11
EA200500775A1 (ru) 2005-12-29
DE10255040A1 (de) 2004-06-03
NO20053089L (no) 2005-06-23
WO2004048373A1 (de) 2004-06-10
ZA200502946B (en) 2005-11-23

Similar Documents

Publication Publication Date Title
RS65604A (sr) Novi estri fluorenkarbonske kiseline, postupak za njihovo pripremanje, kao i njihova upotreba kao lekova
MEP39908A (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
CY1106969T1 (el) Αναστολεις dpp-iv
UY27976A1 (es) Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia
MEP58808A (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
HRP20041042A2 (hr) Novi supstituirani derivati sulfamata kao antikonvulzivi
BRPI0408347A (pt) derivados de pirimidina
BRPI0112986B8 (pt) compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos
HRP20050532A2 (en) Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
MEP59808A (en) Xanthine derivative, production and use thereof as a medicament
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
MXPA02011370A (es) Iminoazinas substituidas.
RS20050384A (sr) Estri karbaminske kiseline sa antiholinergičkim dejstvom
ECSP045497A (es) &#34;difenilazetidinonas sustituidas con grupos acidos, metodo para su producción, medicamentos que comprenden dichos compuestos y su uso&#34;
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
BR0215277A (pt) Dicetopiperazinas substituìdas como antagonistas da oxitocina
HRP20050158A2 (en) Novel 2-arylthiazole compounds as pparalpha and ppargama agonists
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
WO2001066527A8 (de) Substituierte benzoylcyclohexenone
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
BRPI0407335A (pt) Agentes antibacterianos
ECSP045372A (es) Inhibidores de la carboxipeptidasa b plasmática